Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al

PUI-YING LEONGJAMES CHENG-CHUNG WEI2026-10-162026-10-162020-09-15Pure ID: 15149896Pure UUID: 583ba7bd-ec94-4178-bcc2-6a47ace6cb5310.1136/annrheumdis-2020-218779https://www.scopus.com/pages/publications/85091772625https://scholars.csmu.edu.tw/handle/123456789/28987enCorrespondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et aljournal article